Mylan’s EpiPen dilemma won’t be fading soon. After a rush by lawmakers to castigate the company for ‘outrageous’ price increases, Senators Susan Collins (R-ME…

Lundbeck’s focus on the U.S. is paying off. And it’s a good thing, too. While revenue in its native Europe slid by one-fourth in the first half of this year, U…

A federal complaint filed by Turing Chief Commercial Officer Nancy Retzlaff accuses Shkreli friend and Turing co-founder Edwin Urrutia of sexually attacking…

EpiPen has buzz. Unfortunately for Mylan, the buzz isn’t good. FiercePharma has been tracking the story for months: Price hikes, marketing tactics, executive…

Pharma companies are discovering that developing apps and digital health technologies is just like developing drugs--at least when it comes to persuading…

Right now, GlaxoSmithKline’s meningitis B vaccine, Bexsero, doesn’t have the key “universal use” endorsement the company wants from the CDC. So it’s spreading…

Mylan has been pummeled by media, consumers, patients, pundits, politicians and even celebrities over charges of jacking up the price for its EpiPen auto…

India’s Sun Pharma has had a host of problems at some of its own manufacturing facilities in India but it just narrowly escaped another warning letter for a…